June 7 (SeeNews) - Romanian state-controlled drug maker Antibiotice [BSE:ATB] will benefit from an investment of around 100 million euro ($108.96 million) financed through EU funds to boost production of critical medicines, Adrian Caciu, minister of European investments and projects, said.